All In MedTech

Device Trial Radar · NCT01717469

Safety and the Effects of Isolated Left Ventricular Pacing in Patients With Bradyarrhythmias

Randomized Clinical Study to Assess the Safety and the Effects of Isolated Left Ventricular Pacing in Patients With Bradyarrhythmias

Last checked: Nov 19, 2026Latest source record: Nov 6, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

12

Planned (sponsor's estimate)

Start

Jun 2012

Primary completion

Jun 2015

Study completion Jun 2017

Sponsor

Lead sponsor
University of Sao PauloAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Duke University
First posted
Oct 30, 2012

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Previous experimental and clinical studies have consistently suggested that right ventricular (RV) apical pacing has important adverse effects. Ventricular pacing, however, is required, and cannot be reduced in many patients with atrioventricular block. The SAFE-LVPACE study is a randomized controlled trial that compare the effects of conventional right ventricular (RV) pacing vs. left ventricular (LV) in patients with AV block.

Conditions

  • Bradyarrhythmias
  • Arrhythmias
  • Atrioventricular Block
  • Ventricular Dysfunction
  • Cardiovascular Disease

Interventions

  • Left ventricular pacing through coronary sinus tributaries (Attain StarFix)Device

    Left ventricular pacing in patients with bradycardia

  • Right ventricular pacing (Medtronic)Device

    Conventional right ventricular pacing in patients with bradycardia.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Surgical successTime frame: Participants will be evaluated during the perioperative period and during the hospital stay, an expected average of 2 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Heart Institute (InCor) do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

    São Paulo, São Paulo, Brazil · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.